Literature DB >> 34050414

Experimental Evaluation of Long-Term Toxic Effects of Methotrexate on Male Reproductive System.

T G Borovskaya1, Yu A Shchemerova2, E A Bokhan2, V A Grigor'eva2, A V Vychuzhanina2, M E Poluektova2, V E Goldberg3, A M Dygai2.   

Abstract

The morphological and functional state of the reproductive system was studied in male outbred rats (SD stock) and male F1(CBA×C57BL/6) mice after long-term (3 months) methotrexate administration. The drug was administered subcutaneously once a week for 4 weeks, the dose for male rats was 1 mg/kg, for male mice 2.2 mg/kg. It was found that male rats retained the ability to conceive, their reproductive potential was not limited by increased risk of embryo death. At the same time, signs of astheno- and pathospermia were revealed. The testicular tissue was characterized by reduced content of the sources of the proliferative pool of spermatogenesis. In mice treated with methotrexate, increased content of DNA breaks was detected in the testicular cells.

Entities:  

Keywords:  delayed toxic effects; methotrexate; mice; rats; spermatogenesis

Mesh:

Substances:

Year:  2021        PMID: 34050414     DOI: 10.1007/s10517-021-05167-7

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  8 in total

1.  Risk of Adverse Pregnancy Outcome After Paternal Exposure to Methotrexate Within 90 Days Before Pregnancy.

Authors:  Lasse Karlsen Eck; Thomas Bo Jensen; Dimitrios Mastrogiannis; Arendse Torp-Pedersen; Bjarke Askaa; Torben Kjær Nielsen; Henrik Enghusen Poulsen; Espen Jimenez-Solem; Jon Trærup Andersen
Journal:  Obstet Gynecol       Date:  2017-04       Impact factor: 7.661

Review 2.  The toxicity of methotrexate in male fertility and paternal teratogenicity.

Authors:  Jennifer Christine Gutierrez; Kathleen Hwang
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-09-09       Impact factor: 4.481

3.  Are Sertoli cells a kind of mesenchymal stem cells?

Authors:  Daoyuan Gong; Chunfu Zhang; Tao Li; Jiahui Zhang; Nannan Zhang; Zehua Tao; Wei Zhu; Xiaochun Sun
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

4.  Cardiovascular inflammation is reduced with methotrexate in diabetes.

Authors:  Adrian Quan; Yi Pan; Krishna K Singh; John Polemidiotis; Hwee Teoh; Howard Leong-Poi; Subodh Verma
Journal:  Mol Cell Biochem       Date:  2017-03-16       Impact factor: 3.396

5.  Cytotoxic and genotoxic effects of methotrexate in germ cells of male Swiss mice.

Authors:  S Padmanabhan; D N Tripathi; A Vikram; P Ramarao; G B Jena
Journal:  Mutat Res       Date:  2008 Aug-Sep       Impact factor: 2.433

6.  Methotrexate Is a JAK/STAT Pathway Inhibitor.

Authors:  Sally Thomas; Katherine H Fisher; John A Snowden; Sarah J Danson; Stephen Brown; Martin P Zeidler
Journal:  PLoS One       Date:  2015-07-01       Impact factor: 3.240

7.  Methotrexate induces DNA damage and inhibits homologous recombination repair in choriocarcinoma cells.

Authors:  Lisha Xie; Tiancen Zhao; Jing Cai; You Su; Zehua Wang; Weihong Dong
Journal:  Onco Targets Ther       Date:  2016-11-17       Impact factor: 4.147

8.  Assessment and Comparison of the Efficacy of Methotrexate, Prednisolone, Adalimumab, and Tocilizumab on Multipotency of Mesenchymal Stem Cells.

Authors:  Shuang Liu; Takeshi Kiyoi; Marina Ishida; Masaki Mogi
Journal:  Front Pharmacol       Date:  2020-07-03       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.